• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能否延缓 COPD 中的加速肺老化?抗衰老分子和干预措施。

Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions.

机构信息

3rd Respiratory Medicine Department, Sismanogleio General Hospital, Athens, Greece.

出版信息

Curr Drug Targets. 2013 Feb;14(2):149-57. doi: 10.2174/1389450111314020003.

DOI:10.2174/1389450111314020003
PMID:23256715
Abstract

Chronic obstructive pulmonary disease (COPD) has been recently characterized as a disease of accelerated lung aging. The prevalence of COPD is age-dependent suggesting an intimate relationship between the pathogenesis of COPD and aging. Lung function decline, the hallmark feature of COPD evolution, is more prominent with increasing age and this decline is greater in smoking individuals. One of the major goals of COPD pharmacotherapy is the development of drugs that would be able to result in a decrease of the decline in lung function over years. However, till nowadays smoking cessation is the only known intervention which is able to decelerate lung function decline. Several mechanisms of aging, including oxidative stress, inflammation and telomere shortening have been shown to be implicated in COPD. Furthermore, numerous anti-aging molecules, including sirtuins and Nrf-2 are reduced, and pathways such as mTOR and genes such as Klotho have also been shown to be abnormal in the lungs of COPD patients. The above mechanisms have been associated with the accelerated lung aging in COPD patients. Numerous therapeutic interventions have been studied in an attempt to reverse accelerated lung aging, and some of them have already been tested in clinical trials. The aim of the present review is to summarize the mechanisms associated with the accelerated lung aging in COPD and to provide information about the possible therapeutic implications targeting those mechanisms.

摘要

慢性阻塞性肺疾病(COPD)最近被描述为一种加速肺衰老的疾病。COPD 的患病率与年龄有关,这表明 COPD 的发病机制与衰老之间存在密切关系。肺功能下降是 COPD 演变的标志性特征,随着年龄的增长,肺功能下降更为明显,而在吸烟人群中更为明显。COPD 药物治疗的主要目标之一是开发能够降低多年来肺功能下降的药物。然而,到目前为止,戒烟是唯一已知的能够减缓肺功能下降的干预措施。包括氧化应激、炎症和端粒缩短在内的几种衰老机制已被证明与 COPD 有关。此外,许多抗衰老分子,包括沉默调节蛋白和 Nrf-2 减少,以及 mTOR 途径和 Klotho 等基因也被证明在 COPD 患者的肺部异常。上述机制与 COPD 患者的加速肺衰老有关。已经研究了许多治疗干预措施,试图逆转加速的肺衰老,其中一些已经在临床试验中进行了测试。本综述的目的是总结与 COPD 加速肺衰老相关的机制,并提供有关针对这些机制的可能治疗意义的信息。

相似文献

1
Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions.我们能否延缓 COPD 中的加速肺老化?抗衰老分子和干预措施。
Curr Drug Targets. 2013 Feb;14(2):149-57. doi: 10.2174/1389450111314020003.
2
COPD as a disease of accelerated lung aging.慢性阻塞性肺疾病是一种肺部加速衰老的疾病。
Chest. 2009 Jan;135(1):173-180. doi: 10.1378/chest.08-1419.
3
Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?慢性阻塞性肺疾病是一种加速衰老性疾病吗?
Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S429-S437. doi: 10.1513/AnnalsATS.201602-124AW.
4
Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD).加速肺老化:慢性阻塞性肺疾病(COPD)的一种新型致病机制。
Biochem Soc Trans. 2009 Aug;37(Pt 4):819-23. doi: 10.1042/BST0370819.
5
Influencing the decline of lung function in COPD: use of pharmacotherapy.影响 COPD 肺功能下降的因素:药物治疗的应用。
Int J Chron Obstruct Pulmon Dis. 2010 Jun 3;5:153-64. doi: 10.2147/copd.s4577.
6
Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD.各种代表衰老过程的机制途径在 COPD 中发生改变。
Chest. 2016 Jan;149(1):53-61. doi: 10.1378/chest.15-0645. Epub 2016 Jan 6.
7
Senescence in COPD and Its Comorbidities.COPD 中的衰老及其合并症。
Annu Rev Physiol. 2017 Feb 10;79:517-539. doi: 10.1146/annurev-physiol-022516-034314. Epub 2016 Dec 9.
8
STOP accelerating lung aging for the treatment of COPD.停止加速肺衰老以治疗慢性阻塞性肺疾病。
Exp Gerontol. 2014 Nov;59:21-7. doi: 10.1016/j.exger.2014.03.014. Epub 2014 Apr 5.
9
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.慢性阻塞性肺疾病和特发性肺纤维化中的异常肺老化。
Am J Respir Crit Care Med. 2012 Aug 15;186(4):306-13. doi: 10.1164/rccm.201202-0282PP. Epub 2012 May 10.
10
Accelerated lung aging and chronic obstructive pulmonary disease.加速肺老化与慢性阻塞性肺疾病。
Expert Rev Respir Med. 2019 Apr;13(4):369-380. doi: 10.1080/17476348.2019.1580576. Epub 2019 Feb 21.

引用本文的文献

1
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments.炎症与氧化应激在人类疾病中的作用:从分子机制到新疗法。
Int J Mol Sci. 2019 Sep 10;20(18):4472. doi: 10.3390/ijms20184472.
2
Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs - a pilot study.慢性烟雾暴露豚鼠血小板中观察到的线粒体功能异常——一项初步研究。
Int J Chron Obstruct Pulmon Dis. 2018 Nov 9;13:3707-3717. doi: 10.2147/COPD.S175444. eCollection 2018.
3
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.
双重敲除小鼠四跨膜蛋白 CD9 和 CD81 导致类似于加速衰老的综合征。
Sci Rep. 2018 Mar 23;8(1):5145. doi: 10.1038/s41598-018-23338-x.
4
Human Lung Tissue Transcriptome: Influence of Sex and Age.人类肺组织转录组:性别和年龄的影响
PLoS One. 2016 Nov 30;11(11):e0167460. doi: 10.1371/journal.pone.0167460. eCollection 2016.
5
Sirtuin 1 and aging theory for chronic obstructive pulmonary disease.沉默调节蛋白1与慢性阻塞性肺疾病的衰老理论
Anal Cell Pathol (Amst). 2015;2015:897327. doi: 10.1155/2015/897327. Epub 2015 Jul 5.
6
Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage.巨噬细胞移动抑制因子是香烟烟雾诱导肺损伤的一个新的决定因素。
Am J Respir Cell Mol Biol. 2014 Jul;51(1):94-103. doi: 10.1165/rcmb.2013-0371OC.
7
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.慢性阻塞性肺疾病(COPD)中动脉粥样硬化与心血管风险增加之间的潜在机制:聚焦于沉默调节蛋白
Int J Mol Sci. 2013 Jun 17;14(6):12696-713. doi: 10.3390/ijms140612696.